# Prospective Evaluation of Proclarix® Test to Improve Risk Stratification in Men Scheduled for MpMRI and Prostate Biopsy in Cantonal Hospital Aarau

> **NCT06637267** · — · RECRUITING · sponsor: **Kantonsspital Aarau** · enrollment: 480 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Proclarix®

## Key facts

- **NCT ID:** NCT06637267
- **Lead sponsor:** Kantonsspital Aarau
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-08-24
- **Primary completion:** 2025-12-30
- **Final completion:** 2026-12-30
- **Target enrollment:** 480 (ESTIMATED)
- **Last updated:** 2024-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06637267

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06637267, "Prospective Evaluation of Proclarix® Test to Improve Risk Stratification in Men Scheduled for MpMRI and Prostate Biopsy in Cantonal Hospital Aarau". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06637267. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*